Search details
1.
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.
EMBO J
; 38(5)2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30723117
2.
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Acta Biochim Biophys Sin (Shanghai)
; 55(6): 956-973, 2023 Jun 09.
Article
in English
| MEDLINE | ID: mdl-37294106
3.
Light localization in defective periodic photonic moiré-like lattices.
J Opt Soc Am A Opt Image Sci Vis
; 39(12): 2291-2297, 2022 Dec 01.
Article
in English
| MEDLINE | ID: mdl-36520748
4.
Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain.
Cell Biol Toxicol
; 36(5): 399-416, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32002708
5.
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer.
Nucleic Acids Res
; 46(4): 1895-1911, 2018 02 28.
Article
in English
| MEDLINE | ID: mdl-29309643
6.
PubAngioGen: a database and knowledge for angiogenesis and related diseases.
Nucleic Acids Res
; 43(Database issue): D963-7, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25392416
7.
LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.
J Pharmacol Exp Ther
; 355(3): 473-83, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26377911
8.
Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
Eur J Med Chem
; 272: 116494, 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38749268
9.
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.
Signal Transduct Target Ther
; 9(1): 13, 2024 01 08.
Article
in English
| MEDLINE | ID: mdl-38185721
10.
Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4.
Genes Dis
; 11(4): 101164, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38560505
11.
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.
Signal Transduct Target Ther
; 7(1): 198, 2022 06 24.
Article
in English
| MEDLINE | ID: mdl-35750683
12.
Mutated SPOP E3 Ligase Promotes 17ßHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Cancer Res
; 81(13): 3593-3606, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33762355
13.
Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122.
Front Oncol
; 11: 650919, 2021.
Article
in English
| MEDLINE | ID: mdl-34150618
14.
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG.
Adv Sci (Weinh)
; 8(20): e2102555, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34397171
15.
SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
Nat Commun
; 12(1): 5779, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34599168
16.
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
Nat Commun
; 12(1): 1521, 2021 03 09.
Article
in English
| MEDLINE | ID: mdl-33750801
17.
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
J Clin Invest
; 131(14)2021 07 15.
Article
in English
| MEDLINE | ID: mdl-34101624
18.
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.
Oncogene
; 39(42): 6556-6571, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32917955
19.
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression.
Adv Sci (Weinh)
; 7(9): 1903483, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32382484
20.
A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
J Exp Clin Cancer Res
; 38(1): 422, 2019 Oct 22.
Article
in English
| MEDLINE | ID: mdl-31640758